Table 1.
Gastric type | Intestinal type | Pancreatobiliary type | Oncocytic type | |
---|---|---|---|---|
Morphology | Thick finger-like papillae | Villous papillae | Complex thin branching papillae | Complex thick papillae with eosinophilic oncocytic cells |
MUC gene expression | ||||
- MUC 1 | − | − | + | −/+ |
- MUC 2 | − | + | − | −/+ |
- MUC 5AC | + | + | + | + |
- MUC 6 | + | −/+ | −/+ | − |
Percentage of IPMNs | 46–63% | 18–36% | 7–18% | 1–8% |
Location | ||||
- Head | 69–72% | 64–67% | 63–67% | 25–33% |
- Body or tail | 28–31% | 33–37% | 34–37% | 67–75% |
Main-duct involvement | 19% | 63% | 50% | 38% |
Invasive progression | 10% | 40% | 68% | 50% |
Type of adenocarcinoma | Tubular (79%) | Colloid > tubular | Tubular (82%) | Tubular > colloid |
Mural nodules | 30% | 56% | 57% | 100% |
Recurrence rate | 9% | 20% | 46% | 14% |
5-year survival | 85% | 85% | 54% | 79% |
IPMN, intraductal papillary mucinous neoplasm